PolyPeptide Group AG

NEW
XSWX:PPGN (Switzerland)  
CHF 16.68 -0.020 (-0.12%) Apr 22
At Loss
P/B:
1.65
Market Cap:
CHF 550.38M ($ 663.64M)
Enterprise V:
CHF 574.45M ($ 692.66M)
Volume:
36.74K
Avg Vol (2M):
78.17K
Warning! GuruFocus detected 3 Severe warning signs with PPGN. Try a 7-Day Free Trial to check it out.
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
36.74K
Market Cap CHF:
550.38M
Market Cap $:
663.64M
At Loss
Avg Vol (2M):
78.17K
Enterprise Value CHF:
574.45M
Enterprise Value $:
692.66M
PB Ratio:
1.65
Website Sources Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocksâ„¢

Business Description

PolyPeptide Group AG

ISIN : CH1110760852
https://www.polypeptide.com
Neuhofstrasse 24, Baar, Zug, CHE, 6340
Compare
Compare
XSWX:CURNZTSXTER:MRKNSE:SUNPHARMATSE:4502LSE:HLNXSWX:GALDXSWX:SDZHKSE:03692NSE:DIVISLABXTAE:TEVAITCISZSE:000538UTHRBOM:500087TSE:4507SHSE:688506NSE:TORNTPHARMBOM:543904NBIX
Traded in other countries / regions
PPGN.SwitzerlandPPGNz.UK
IPO Date
2021-04-29
Description
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives majority of its revenue from Europe and Asia.

Financial Strength

5/10
Name Current Vs Industry Vs History
Cash-To-Debt 0.73
Equity-to-Asset 0.47
Debt-to-Equity 0.26
Debt-to-EBITDA 3.27
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.79
Distress
Grey
Safe
Beneish M-Score -3.49
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

9/10
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 321.5
3-Year EBITDA Growth Rate -33.2
3-Year Book Growth Rate -8.6
Future 3-5Y Total Revenue Growth Rate Estimate 17.54

Momentum Rank

2/10
Name Current Vs Industry Vs History
5-Day RSI 74.78
9-Day RSI 58.59
14-Day RSI 49.72
3-1 Month Momentum % -32.56
6-1 Month Momentum % -39.13
12-1 Month Momentum % -38.05

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.69
Quick Ratio 0.94
Cash Ratio 0.35
Days Inventory 176.96
Days Sales Outstanding 74.21
Days Payable 71.27

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 0.1
Shareholder Yield % -0.47

Profitability Rank

4/10
Name Current Vs Industry Vs History
Gross Margin % 11.55
Operating Margin % -1.86
Net Margin % -5.81
FCF Margin % 0.45
ROE % -5.37
ROA % -2.79
ROIC % -1.19
3-Year ROIIC % 136.46
ROC (Joel Greenblatt) % -0.98
ROCE % -0.84
Years of Profitability over Past 10-Year 5

GF Value Rank

2/10
Name Current Vs Industry Vs History
Forward PE Ratio 62.55
Price-to-Owner-Earnings 33.94
PS Ratio 1.73
PB Ratio 1.65
Price-to-Tangible-Book 1.72
Price-to-Free-Cash-Flow 877.9
Price-to-Operating-Cash-Flow 6.68
EV-to-EBIT -139.53
EV-to-Forward-EBIT 45.72
EV-to-EBITDA 21.38
EV-to-Forward-EBITDA 15.09
EV-to-Revenue 1.8
EV-to-Forward-Revenue 1.89
EV-to-FCF 400.43
Price-to-GF-Value 0.01
Earnings Yield (Greenblatt) % -0.72
FCF Yield % 0.26

Financials

XSWX:PPGN's 30-Y Financials
AAPL
Income Statement Breakdown FY
Not Enough Data
AAPL
Balance Sheet Breakdown
Not Enough Data
AAPL
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

PolyPeptide Group AG Executives

Details

GF Value: CHF2469.93

XSWX:PPGN

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil CHF) 320.074
EPS (TTM) (CHF) -0.561
Beta 1.48
3-Year Sharpe Ratio -0.35
3-Year Sortino Ratio -0.57
Volatility % 38.39
14-Day RSI 49.72
14-Day ATR (CHF) 0.908932
20-Day SMA (CHF) 15.982
12-1 Month Momentum % -38.05
52-Week Range (CHF) 13.22 - 35.8
Shares Outstanding (Mil) 33

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

PolyPeptide Group AG Filings

Filing Date Document Date Form
No Filing Data

PolyPeptide Group AG Stock Events

Financials Calendars
Event Date Price (CHF)
No Event Data

PolyPeptide Group AG Frequently Asked Questions

What is PolyPeptide Group AG(XSWX:PPGN)'s stock price today?
The current price of XSWX:PPGN is CHF16.68. The 52 week high of XSWX:PPGN is CHF35.80 and 52 week low is CHF13.22.
When is next earnings date of PolyPeptide Group AG(XSWX:PPGN)?
The next earnings date of PolyPeptide Group AG(XSWX:PPGN) is .
Does PolyPeptide Group AG(XSWX:PPGN) pay dividends? If so, how much?
PolyPeptide Group AG(XSWX:PPGN) does not pay dividend.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.